Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter P Jeske

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Best Practice & Research. Clinical Haematology|June 3, 2004
Small-molecule direct antithrombins: argatrobanJawed Fareed, Walter P Jeske
Methods in Molecular Medicine|January 22, 2004
Antithrombotic drugs for the treatment of heparin-induced thrombocytopeniaWalter P Jeske, Jeanine M Walenga
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Antithrombotic drugs for the treatment of heparin-induced thrombocytopeniaWalter P Jeske, Jeanine M Walenga
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Prasugrel: a novel platelet ADP P2Y(12) receptor antagonistShaker A Mousa, Walter P Jeske, Jawed Fareed
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2010
Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonistShaker A Mousa, Walter P Jeske, Jawed Fareed
Methods in Molecular Medicine|January 22, 2004
Laboratory methods for heparin-induced thrombocytopeniaMargaret Prechel, Walter P Jeske, Jeanine M Walenga
Expert Opinion on Investigational Drugs|July 19, 2005
Short- and long-acting synthetic pentasaccharides as antithrombotic agentsJeanine M Walenga, Walter P Jeske, Jawed Fareed
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Laboratory methods and management of patients with heparin-induced thrombocytopeniaMargaret Prechel, Walter P Jeske, Jeanine M Walenga
Methods in Molecular Medicine|January 22, 2004
A survey of venous thrombosis modelsWalter P Jeske, Omer Iqbal, Jawed Fareed, et al.
Thrombosis Research|November 26, 2009
Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopeniaM Margaret Prechel, Walter P Jeske, Jeanine M Walenga
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Best Practice & Research. Clinical Haematology|June 3, 2004
Small-molecule direct antithrombins: argatrobanJawed Fareed, Walter P Jeske
Methods in Molecular Medicine|January 22, 2004
Antithrombotic drugs for the treatment of heparin-induced thrombocytopeniaWalter P Jeske, Jeanine M Walenga
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Antithrombotic drugs for the treatment of heparin-induced thrombocytopeniaWalter P Jeske, Jeanine M Walenga
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Prasugrel: a novel platelet ADP P2Y(12) receptor antagonistShaker A Mousa, Walter P Jeske, Jawed Fareed
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2010
Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonistShaker A Mousa, Walter P Jeske, Jawed Fareed
Methods in Molecular Medicine|January 22, 2004
Laboratory methods for heparin-induced thrombocytopeniaMargaret Prechel, Walter P Jeske, Jeanine M Walenga
Expert Opinion on Investigational Drugs|July 19, 2005
Short- and long-acting synthetic pentasaccharides as antithrombotic agentsJeanine M Walenga, Walter P Jeske, Jawed Fareed
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Laboratory methods and management of patients with heparin-induced thrombocytopeniaMargaret Prechel, Walter P Jeske, Jeanine M Walenga
Methods in Molecular Medicine|January 22, 2004
A survey of venous thrombosis modelsWalter P Jeske, Omer Iqbal, Jawed Fareed, et al.
Thrombosis Research|November 26, 2009
Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopeniaM Margaret Prechel, Walter P Jeske, Jeanine M Walenga
Pageof 5